Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The role of blocking antibodies in immunological enhancement.

× No keyword cloud information.

19 in total

1. Inhancement activity of mouse immunoglobulin classes.

Authors: G L Irvin; J C Eustace; J L Fahey
Journal: J Immunol Date: 1967-12 Impact factor: 5.422

2. Transplantation immunity: localization in mouse serum of antibodies responsible for haemagglutination, cytotoxicity and enhancement.

Authors: G A Voisin; R G Kinsky; F K Jansen
Journal: Nature Date: 1966-04-09 Impact factor: 49.962

3. Antibody production studied by means of the localized haemolysis in gel (LHG) assay. 3. Mouse cells producing five different classes of antibody.

Authors: H H Wortis; D W Dresser; H R Anderson
Journal: Immunology Date: 1969-07 Impact factor: 7.397

4. Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs.

Authors: K T Brunner; J Mauel; J C Cerottini; B Chapuis
Journal: Immunology Date: 1968-02 Impact factor: 7.397

5. Regulation of immunity toward allogeneic tumors in mice. II. Effect of antiserum and antiserum fractions on cellular and humoral response.

Authors: M Takasugi; W H Hildemann
Journal: J Natl Cancer Inst Date: 1969-10 Impact factor: 13.506

6. Immunological enhancement by mouse isoantibodies: the importance of complement fixation.

Authors: T Chard
Journal: Immunology Date: 1968-04 Impact factor: 7.397

7. A microassay for cell-mediated immunity.

Authors: M Takasugi; E Klein
Journal: Transplantation Date: 1970-03 Impact factor: 4.939

8. Immunologic enhancement of sarcoma I by mouse gamma-globulin fractions.

Authors: S Tokuda; F McEntee
Journal: Transplantation Date: 1967-07 Impact factor: 4.939

9. Regulation of immunity toward allogeneic tumors in mice. I. Effect of antiserum fractions on tumor growth.

Authors: M Takasugi; W H Hildemann
Journal: J Natl Cancer Inst Date: 1969-10 Impact factor: 13.506

10. Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens.

Authors: I Hellström; K E Hellström; C A Evans; G H Heppner; G E Pierce; J P Yang
Journal: Proc Natl Acad Sci U S A Date: 1969-02 Impact factor: 11.205

6 in total

1. Fate of skin allografts in normal mice injected with antigraft strain globulin in relation to the IgG1 and IgG2 class of the antibodies.

Authors: T N Harris; S Harris
Journal: Immunology Date: 1973-09 Impact factor: 7.397

2. Suppression and enhancement of allografted tumour.

Authors: M Yutoku; H Seno; Y Matsuoka; M Kitagawa
Journal: Immunology Date: 1974-03 Impact factor: 7.397

3. Isoantiserum-augmented development of lymphocyte-mediated cytotoxicity.

Authors: R Faanes; M Walker; Y S Choi
Journal: J Exp Med Date: 1976-11-02 Impact factor: 14.307

4. Synergistic or antgonistic effect of different antibody concentrations on in vitro lymphocyte cytotoxicity in the Moloney sarcoma virus system.

Authors: H M Skurzak; E Klein; T O Yoshida; E W Lamon
Journal: J Exp Med Date: 1972-04-01 Impact factor: 14.307

5. Serological response to intracaecal injections of antigenic mouse tumour cells.

Authors: M L Laursen
Journal: Br J Cancer Date: 1978-12 Impact factor: 7.640

6. Release of soluble "blocking" and "suppressor" factors from normal lymphocytes treated with RNA from spleens of tumour-bearing mice.

Authors: K J Pennline; S B Evans; J F Nawrocki; J C Rees; C S Johnson; D A Vallera; M C Dodd
Journal: Br J Cancer Date: 1979-03 Impact factor: 7.640

6 in total